BRC

Analyst Note: Brady Corporation (BRC)

Date: 2026-06-13 Current Price: $85.31

1. Structural Readiness

State: Forming Conservative Entry: Not yet defined (requires a confirmed breakout close above the coil high). Aggressive/Pre-Breakout Entry: $85.31 (Current Price). Breakout Level: Not yet defined (requires price to close above the coil high). Extension: Not applicable (price is within the consolidation range, not extended above the breakout). ATR Context: Current ATR is 4.0% (High). This indicates elevated volatility, which is consistent with the "High" bucket (4–6%) often seen in quality compounders approaching a catalyst or re-rating.

2. Thesis Layer

Thesis Classification: TACTICAL / Setup-Led Secular Exposure: None named at this date. Analysis: As of June 13, 2026, BRC is not being analyzed through a specific macro or secular theme lens (e.g., "AI Infrastructure" or "Green Energy Transition"). The investment case is strictly driven by the quality of the technical setup (the forming coil) and the fundamental strength of the business as reported in the most recent earnings and filings. The conviction rests on the company's ability to execute its growth strategy and the structural quality of the price action, rather than a broad market tailwind.

3. Business Overview

Company Profile: Brady Corporation is a global manufacturer and supplier of identification and direct part marking solutions, high-performance materials, and workplace safety products. The company serves a diverse client base across industrial manufacturing, electronic manufacturing, healthcare, chemical, oil & gas, automotive, aerospace, and government sectors. Business Model: The company operates through two primary segments: Identification Solutions (IDS) and Workplace Safety (WPS).

Recent Performance & Strategy (as of May 18, 2026):

• IDS: Provides safety signs, floor-marking tapes, pipe markers, labeling systems, and RFID/barcode scanners. It also offers software for safety compliance auditing and training.
• WPS: Focuses on safety and compliance signage, tags, labels, and PPE, distributed via catalog and digital channels.
• Growth: Net sales for the quarter ended April 30, 2026, increased 13.8% to $435.2 million. This included 8.2% organic sales growth, 2.1% from acquisitions, and 3.5% from foreign currency.
• Segment Performance: Organic sales grew 10.1% in the Americas & Asia segment and 4.5% in Europe & Australia.
• Strategic Acquisition: On April 20, 2026, Brady entered an agreement to acquire Honeywell's Productivity Solutions and Services (PSS) business for $1.4 billion in cash. Management expects this acquisition to close in the second half of calendar 2026 (best estimate: August 1, pending regulatory filings).
• Synergies: Management expects the PSS business to be immediately accretive, adding approximately $0.80 of adjusted EPS in the first year.
• Guidance: Management raised full-year adjusted EPS guidance to a range of $5.20 to $5.30 (up from $4.95–$5.15) and expects mid-single-digit organic sales growth for the full year ending July 31, 2026.
• R&D: The company continues to invest in innovation, with R&D expenses of $79.9 million for the year ended July 31, 2025.

4. Archetype and Conviction

Archetype: Quality Compounder Fit Rationale: BRC fits the "Quality Compounder" archetype due to its consistent history of acquisitions (Gravotech, AB&R, Microfluidic Solutions in FY2025; pending Honeywell PSS), disciplined capital allocation, and ability to generate organic growth alongside M&A. The business model is characterized by high switching costs (safety compliance, asset tracking) and a broad, diversified customer base (no single customer >10% of sales). Valuation & Financials:

ATR Context: The 4.0% ATR (High) suggests the stock is active and responsive to news, which is favorable for a compounder approaching a catalyst (the acquisition close).

• Forward Consensus: FY1 EPS consensus is $5.275; FY2 is $5.90.
• Current Price Context: At $85.31, the stock trades at approximately 16.2x FY1 consensus and 14.4x FY2 consensus.
• Conviction Stack:
• Thesis Strength: Moderate (Tactical, no macro tailwind).
• Evidence Quality: High. Recent earnings (May 18) show strong execution, raised guidance, and a clear path to EPS accretion from the Honeywell deal.
• Structural Quality: High. The "Forming" coil indicates a healthy consolidation after a run-up, with price holding above support.
• Setup Readiness: Partial. The structure is in place, but the breakout has not fired.
• Rerating Potential: Moderate to High. The combination of raised guidance and the strategic expansion into mobile computing/barcode scanning (via PSS) could drive a multiple expansion if the acquisition closes smoothly.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Successful regulatory approval and closing of the Honeywell PSS acquisition by the August 1 estimate.
• Continued organic growth acceleration in the Americas & Asia segment (currently 10.1%).
• Confirmation that the PSS acquisition delivers the projected $0.80 EPS accretion in the first year.
• A confirmed breakout close above the coil high, validating the "Forming" structure.

What Would Invalidate the Case:

• Regulatory rejection or significant delay of the Honeywell PSS acquisition.
• A material miss on the raised EPS guidance ($5.20–$5.30) or organic growth targets.

Gaps in Evidence:

• Integration Risk: While management expects immediate accretion, there is no specific evidence in the provided text regarding the integration timeline or potential synergies beyond the $0.80 EPS estimate.
• Regulatory Specifics: The "customary closing conditions" and "regulatory filings" mentioned are generic; specific regulatory hurdles in key markets (EU Digital Product Passport, etc.) are not detailed in the evidence.
• Debt Capacity: The $1.4 billion cash purchase price is noted, but the specific impact on the balance sheet leverage ratio post-acquisition is not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Raised full-year adjusted EPS guidance to $5.20-$5.30; Organic sales growth of 8.2% in Q1 2026; Strategic acquisition of Honeywell PSS expected to add $0.80 EPS accretion in year one; Price holding above structural support in a forming coil. Key risks: Regulatory delays or rejection of the Honeywell PSS acquisition; Integration execution risk failing to meet accretion targets; Elevated volatility (4.0% ATR) leading to false breakouts or breakdowns. Sizing hint: Position size should reflect the "forming" nature of the setup; allocate based on the conviction in the fundamental thesis while waiting for the technical breakout confirmation. Expected path: Management expects the acquisition to close in H2 2026, driving EPS accretion and expanding the TAM. The stock should consolidate near current levels until the deal closes or a technical breakout occurs. Expected horizon: 6 to 12 months (aligned with acquisition closing and full-year guidance realization).